Paul Calabresi Career Development Award for Clinical Oncology (K12)The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) K12 (NIH Institutional Research Career Development K12 grant mechanism) is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s, nurses with Ph.D.s or equivalent) and Ph.D. scientists who are trained to design and test clinical therapeutic research protocols (pilot/Phase I, Phase II, and Phase III clinical trials), conduct patient-oriented cancer therapeutic research in team research environments, and to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research.
A PCACO can support the research career development of senior fellow and/or junior faculty level clinicians (single track) or senior fellow and/or junior faculty level clinicians and postdoctoral Ph.D. scientists (dual track). Clinical and Ph.D. scientists will collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train scientists for laboratory-based research. The PCACO provides up to 5 years of support and is renewable.
For more complete information, reference the Program Announcement and/or contact the program staff.
At the time of the award, the PI must be:
Established Investigators (Associate and Full Professors)
Researchers from diverse backgrounds are encouraged to participate as mentors.
At the time of the award, the scholar must be:
Scholar must be:
|MD: PhD Ratio||2:1|
Scholar must commit a minimum of 9 calendar months (75% of full-time professional effort) to research and career development.
Scholars who have U.S. Veterans' Administration (VA) appointments may not consider part of the VA effort toward satisfying the "full time" requirement at the applicant institution.
|Duration of Award||2 to 4 years of support|
|Direct Cost Limits||
All applications must not exceed $750,000 for direct costs per year.
The first year's direct costs budget is capped at $50,000. This first year is for advertising and recruitment of Scholars, Advisory Board(s) recruitment and meeting, curriculum planning and development and development of individual Scholar's curricula.
Up to $10,000 total per annum may be allocated for all PDs/PIs of the K12 programs to partially offset their salaries and associated fringe benefit costs, depending on commitment of effort.
The costs of a consultant, Program Administrator and/or program assistant with responsibilities directly associated with the institutional career development program can be requested with justification.
|F&A Costs/Indirect Costs||8%|
|Salary||Up to $100K/year + fringe benefits|
|Research Development Support||Up to $30K/year|
How to Apply
- Applicants must submit applications electronically – download the K12 Award application
- Applicants must use the SF424 (R&R) Application Guide. Because the instructions in the SF424(R&R) do not fully apply to the special needs of the K12 Award, follow the modified instructions that are detailed in the K12 Program Announcement.
- Applications that do not comply with these instructions may be delayed or not be accepted for review
Application Receipt Dates and Review Schedule
Please refer to the Program Announcement for application due dates.
Applications are due by 5 pm local time.
When a standard submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.
Note: Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Review and Selection Process
An appropriate Scientific Review Group (or groups), along with NCI, and the National Cancer Advisory Board (NCAB) will evaluate your application for conformance with eligibility requirements. Subcommittee F convened by the Division of Extramural Activities of the NCI will determine if meets the broad needs of the program and priorities of NCI and the National Cancer Program.
For review criteria for the K12 grant mechanism, see the Section V: Application Review Criteria section of the Program Announcement.
K12 Special Notes
This is an NCI-specific Program Announcement. For all of the policies governing this award mechanism, refer to the Program Announcement: PAR-13-201.
For required Tables for New and Competing Renewal applications, please see Data tables for use with Institutional Research Training grant applications using the SF424 (R&R).
Special Institutional Statement Regarding Human Subjects Research Under K12 Support
The National Cancer Institute (NCI) Paul Calabresi Career Development Award for Clinical Oncology (K12) must be in compliance with all NIH/NCI policies pertaining to the use of human subjects. These policies apply to all research involving human subjects, not just clinical trials.
The K12 is a training and career development grant in which candidate positions are filled at the discretion of the institution and assignment of candidate positions is generally not known at the time of application or at the time of an award. Due to this uncertainty, the word "Indefinite" should be placed in the box for IRB review date on the face page of the application and the applicant institution must provide in the submitted grant application a Special Statement on Human Subjects Research.
- Program Announcement
- K12 Human Subjects Research Statement
- Current List of K12 Awards
- Link to Main Peer Review Group NCI-F
- Application Form and Details
NCI Staff Contacts
For additional information regarding policies and/or guidance in preparing an application for the K12 Award, contact:
- Dr. Mark Damico
- Branch Phone: 240-276-5630
For information regarding fiscal and/or budget issues, contact:
- Grant Management Contact
For information regarding review issues, contact:
- Referral Officer
Division of Extramural Activities